DBVT
DBV Technologies
NASDAQ: DBVT · HEALTHCARE · BIOTECHNOLOGY
$21.00
+3.45% today
Updated 2026-04-30
Market cap
$1.17B
P/E ratio
—
P/S ratio
207.92x
EPS (TTM)
$-5.25
Dividend yield
—
52W range
$8 – $26
Volume
0.2M
WallStSmart proprietary scores
22
out of 100
Grade: F
Strong Sell
Investment rating
5.7
Growth
C+5.0
Quality
C+2.5
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$40.20
+91.43%
12-Month target
—
—
Intrinsic (DCF)
$82.86
Margin of safety
+72.73%
1 Strong Buy4 Buy0 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 26.20% QoQ
+ 72.73% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-35.20M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $4.80M | $15.73M | $2.57M | $0.00 | $5.64M |
| Net income | $-96.30M | $-72.73M | $-113.72M | $-147.40M | $-44.80M |
| EPS | — | — | — | — | $-5.25 |
| Free cash flow | $-56.45M | $-80.33M | $-106.81M | $-121.71M | $-35.20M |
| Profit margin | -2,006.25% | -462.40% | -4,428.22% | — | — |
Peer comparison
Smart narrative
DBV Technologies trades at $21.00. Our Smart Value Score of 22/100 indicates the stock is weak. TTM revenue stands at $5.64M. Our DCF model estimates intrinsic value at $82.86.
Frequently asked questions
What is DBV Technologies's stock price?
DBV Technologies (DBVT) trades at $21.00.
Is DBV Technologies overvalued?
Smart Value Score 22/100 (Grade F, Strong Sell). DCF value $82.86.
What is the price target of DBV Technologies (DBVT)?
The analyst target price is $40.20, representing +91.4% upside from the current price of $21.00.
What is the intrinsic value of DBV Technologies (DBVT)?
Based on our DCF model, intrinsic value is $82.86, a +72.7% margin of safety versus $21.00.
What is DBV Technologies's revenue?
TTM revenue is $5.64M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio207.92x
ROE-149.80%
Beta-0.20
50D MA$20.91
200D MA$15.92
Shares out0.06B
Float0.17B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—